Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HNO International (HNOI) EBITDA (2022 - 2026)

HNO International filings provide 5 years of EBITDA readings, the most recent being -$116852.0 for Q1 2026.

  • On a quarterly basis, EBITDA rose 97.84% to -$116852.0 in Q1 2026 year-over-year; TTM through Jan 2026 was -$1.1 million, a 86.7% increase, with the full-year FY2025 number at -$6.4 million, down 100.31% from a year prior.
  • EBITDA hit -$116852.0 in Q1 2026 for HNO International, up from -$119625.0 in the prior quarter.
  • In the past five years, EBITDA ranged from a high of -$116852.0 in Q1 2026 to a low of -$5.4 million in Q1 2025.
  • Median EBITDA over the past 5 years was -$431268.0 (2025), compared with a mean of -$814478.7.
  • Biggest five-year swings in EBITDA: plummeted 1040.16% in 2025 and later soared 97.84% in 2026.
  • HNO International's EBITDA stood at -$278426.0 in 2022, then plummeted by 240.07% to -$946840.0 in 2023, then plummeted by 81.68% to -$1.7 million in 2024, then surged by 93.05% to -$119625.0 in 2025, then rose by 2.32% to -$116852.0 in 2026.
  • The last three reported values for EBITDA were -$116852.0 (Q1 2026), -$119625.0 (Q4 2025), and -$431268.0 (Q3 2025) per Business Quant data.